These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

875 related items for PubMed ID: 22807098

  • 1. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK, Bertog S, Kaltenbach B, Id D, Franke J, Hofmann I, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [Abstract] [Full Text] [Related]

  • 3. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 4. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan 12; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 5. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 12; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 6. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 7. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG.
    Hypertension; 2014 Sep 09; 64(3):565-72. PubMed ID: 24935940
    [Abstract] [Full Text] [Related]

  • 8. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H, Mylotte D, Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC, ICV-GVM la Roseraie.
    Ann Cardiol Angeiol (Paris); 2013 Dec 09; 62(6):384-91. PubMed ID: 24182849
    [Abstract] [Full Text] [Related]

  • 9. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.
    Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M.
    Circulation; 2011 May 10; 123(18):1940-6. PubMed ID: 21518978
    [Abstract] [Full Text] [Related]

  • 10. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S, Okon T, Heinemann D, Kulle K, Röhnert K, Sonnabend M, Petzold M, Müller U, Schuler G, Eitel I, Thiele H, Lurz P.
    Hypertension; 2015 Jun 10; 65(6):1202-8. PubMed ID: 25824248
    [Abstract] [Full Text] [Related]

  • 11. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H, Jiang X, Liang T, Zou Y, Guan T, Peng M, Song L, Zhang H, Wu H, Xu B, Yang Y, Gao R.
    J Invasive Cardiol; 2014 Jul 10; 26(7):322-7. PubMed ID: 24993989
    [Abstract] [Full Text] [Related]

  • 12. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
    Schirmer SH, Sayed MM, Reil JC, Lavall D, Ukena C, Linz D, Mahfoud F, Böhm M.
    JACC Cardiovasc Interv; 2015 Jun 10; 8(7):972-80. PubMed ID: 26003031
    [Abstract] [Full Text] [Related]

  • 13. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T, Gammer V, Nahler A, Blessberger H, Kammler J, Grund M, Kerschner K, Buchmayr G, Saleh K, Kypta A, Hönig S, Wichert-Schmitt B, Schwarz S, Sihorsch K, Reiter C, Steinwender C.
    Int J Cardiol; 2015 Feb 15; 181():96-101. PubMed ID: 25497527
    [Abstract] [Full Text] [Related]

  • 14. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP, Papademetriou V, Dimitriadis KS, Kasiakogias A, Tsiachris D, Worthley MI, Sinhal AR, Chew DP, Meredith IT, Malaiapan Y, Thomopoulos C, Kallikazaros I, Tousoulis D, Worthley SG.
    Int J Cardiol; 2015 Dec 15; 201():345-50. PubMed ID: 26301677
    [Abstract] [Full Text] [Related]

  • 15. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S, Ormiston J, Bergmann MW, Sievert H, Schwindt A, Werner N, Vogel B, Colombo A.
    EuroIntervention; 2015 Feb 15; 10(10):1221-9. PubMed ID: 25452198
    [Abstract] [Full Text] [Related]

  • 16. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG, Maia GL, de Queiroz Carreira MA, Kiuchi T, Chen S, Andrea BR, Graciano ML, Lugon JR.
    Eur Heart J; 2013 Jul 15; 34(28):2114-21. PubMed ID: 23786861
    [Abstract] [Full Text] [Related]

  • 17. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.
    J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930
    [Abstract] [Full Text] [Related]

  • 18. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H, Schofer J, Ormiston J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J, Cohen-Mazor M.
    EuroIntervention; 2015 Feb 10; 10(10):1213-20. PubMed ID: 25452197
    [Abstract] [Full Text] [Related]

  • 19. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 InvestigatorsCentre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. henry.krum@med.monash.edu.au.
    Hypertension; 2011 May 10; 57(5):911-7. PubMed ID: 21403086
    [Abstract] [Full Text] [Related]

  • 20. [Safety and short-term efficacy of renal sympathetic denervation in the treatment of resistant hypertension].
    Jiang XJ, Liang T, Dong H, Peng M, Ma WJ, Guan T, Zhang HM, Bian J, Xu B, Gao RL.
    Zhonghua Yi Xue Za Zhi; 2012 Dec 11; 92(46):3265-8. PubMed ID: 23328511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.